Prostate Cancer Italy Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015  - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

  • $ 3 500
  • Industry report
  • by Kelly Scientific Publications
  • February 2015
  • 254 pages

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows: • By ...

Industries: Therapy | Countries: Europe, World, France, Germany, United Kingdom, United States, Spain, Italy

Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

Orpea SA (ORP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • January 2015
  • 25 pages

Summary Orpea SA (Orpea) is a healthcare service provider. The company offers clinical care, rehabilitation and psychiatric services. Its clinical care services include sub acute care and rehabilitation, physical medicine and rehabilitation, specialty hematology and oncology rehabilitation. Orpea provides ...

Industries: Therapy | Countries: Switzerland, Spain, Italy, France, Belgium

Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 8 pages

Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI Industry Brief - CHMP Issues Positive Opinion For BI's Nintedani ...

Industries: Therapy | Countries: Canada, Spain, Italy, Germany, Japan, Europe, United Kingdom, World

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • November 2014
  • 66 pages

Summary Chiesi Farmaceutici SpA (Chiesi) is a research focused pharmaceutical company. The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, ...

Industries: Therapy | Countries: World, Italy, Europe, United Kingdom, North America, United States, Czech Republic, France

EU5 Compression Therapy Market Outlook to 2020

EU5 Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 273 pages

EU5 Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "EU5 Compression Therapy Market Outlook to 2020", provides key market data on the EU5 Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: France, Germany, Italy, United Kingdom, Spain, Europe

Italy Compression Therapy Market Outlook to 2020

Italy Compression Therapy Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 70 pages

Italy Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "Italy Compression Therapy Market Outlook to 2020", provides key market data on the Italy Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: Italy

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 4 995
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 4 995
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 4 995
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.